Frank T. Ward
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 4
- Hemoglobinopathies and Related Disorders 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- John A. Kark (3 shared papers)Raymond B. Weiss (3 shared papers)Thomas Maneatis (1 shared paper)Sarah Donegan (1 shared paper)John C. Byrd (1 shared paper)Jamie K. Waselenko (1 shared paper)Christine A. White (1 shared paper)Brian P. Monahan (1 shared paper)
- Journals
- Cancer (4 papers)Journal of Clinical Oncology (1 paper)Seminars in Oncology (1 paper)Journal of Stroke and Cerebrovascular Diseases (1 paper)Blood (1 paper)
- Partner nations
- United StatesIreland
In The Last Decade
Frank T. Ward
13 papers receiving 413 citations
Peers
Comparison fields: 5 of 62
- Genetics 197
- Pathology and Forensic Medicine 161
- Hematology 84
- Oncology 131
- Dermatology 33
Countries citing papers authored by Frank T. Ward
This map shows the geographic impact of Frank T. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank T. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank T. Ward more than expected).
Fields of papers citing papers by Frank T. Ward
This network shows the impact of papers produced by Frank T. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank T. Ward. The network helps show where Frank T. Ward may publish in the future.
Co-authors
The 25 scholars most cited alongside Frank T. Ward, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 209 | |
| 2 | Exercise and hemoglobin S. | 1994 | 75 |
| 3 | 1989 | 61 | |
| 4 | 1996 | 26 | |
| 5 | 1990 | 12 | |
| 6 | Phase I bioavailability and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered via nasogastric tube. | 1991 | 11 |
| 7 | 2014 | 10 | |
| 8 | 2010 | 10 | |
| 9 | 1990 | 6 | |
| 10 | 1998 | 3 | |
| 11 | Sickle Cell Trait and Fatal Exertional Heat Illness: Implications for Exercise-Related Death of Young Ddults | 2008 | 3 |
| 12 | 1998 | 2 | |
| 13 | 1994 | 1 |
About Frank T. Ward
Frank T. Ward is a scholar working on Genetics, Molecular Biology, Pathology and Forensic Medicine, Oncology and Hematology, having authored 13 papers that have together received 429 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (2 papers), Hemoglobinopathies and Related Disorders (2 papers), Economic and Financial Impacts of Cancer (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Methemoglobinemia and Tumor Lysis Syndrome (1 paper), Cancer Risks and Factors (1 paper), Chemical Reactions and Isotopes (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Genetics (197 citations), Pathology and Forensic Medicine (161 citations), Hematology (84 citations), Oncology (131 citations) and Dermatology (33 citations). Frank T. Ward has collaborated with scholars based in United States and Ireland. Frequent co-authors include John A. Kark, Raymond B. Weiss, Thomas Maneatis, Sarah Donegan, John C. Byrd, Jamie K. Waselenko, Christine A. White, Brian P. Monahan, Timothy J. Murphy and Susan Morgan. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Seminars in Oncology, Journal of Stroke and Cerebrovascular Diseases and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.